A phase I study of ADXS-504, a cancer type specific immunotherapy, for patients with biochemically recurrent prostate cancer

JOURNAL OF CLINICAL ONCOLOGY(2022)

引用 0|浏览5
暂无评分
关键词
recurrent prostate cancer,prostate cancer,specific immunotherapy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要